Autolus Therapeutics AnalystMaintains Buy
This is a news story, published by Yahoo Finance, that relates primarily to Needham news.
Needham news
For more Needham news, you can click here:
more Needham newsstocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Autolus Therapeutics plc. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest other treatments news, lymphoblastic leukemia news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Autolus TherapeuticsInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10

81% Informative
Needham reiterated a Buy rating on Autolus Therapeutics plc (NASDAQ:AUTL) on June 12 , keeping the price target at $ 10.00 .
Needham 's Gil Blum cited the promising results of the FELIX study for obe-cel in patients with relapsed/refractory acute lymphoblastic leukemia (ALL) as one of the factors supporting the optimistic rating.
AutolUS Therapeutic company develops programmed T cell therapies for treating autoimmune diseases.
VR Score
78
Informative language
76
Neutral language
44
Article tone
formal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
4
Source diversity
1
Affiliate links
no affiliate links